Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Apple Is Under Pressure and May See $100 Before $140

Although AAPL stock has probably peaked for now, long-term investors in Apple may consider buying the dips.

Plan Your EV SPAC Attack With Tortoise Acquisition Stock

As SHLL stock undergoes a transition, electric vehicle enthusiasts can capitalize on the electrification of the commercial vehicle market.

Now That Everybody Loves Nio, It’s Time to Start Taking Profits

Sure, Nio is in hyper-growth mode as a developing automobile manufacturer. Still, the share-price move in Nio stock should raise a red flag.

JFrog Shares Jumped High Post-IPO, but Now It’s Time for Caution

In a year of IPO mania, it's time to consider the possibility that the leap in the FROG stock price is mostly the result of hype.

Paychex Earnings: PAYX Stock Ticks 1% Lower on Rough Q1 Figures, Bad Outlook

Paychex earnings on Tuesday have PAYX stock a bit lower after the company reported rough Q1 figures and provided a dismal outlook for FY2021.

What Is Spartan Energy Acquisition and Is It a Buy?

Spartan Energy Acquisition has done well, with the SPAC space carrying plenty of momentum. But does that make SPAQ stock a buy right now?

Will Spartan Energy Stock Crash Like Nikola Did?

If the collapse of Nikola stock got you thinking about SPAQ stock's fate, you're not alone. But should investors really be worried?

OGEN Stock: Why Oragenics Is Soaring 25%

Oragenics is planning to launch clinical trials of its coronavirus vaccine in early 2021. OGEN stock is soaring on the news.

Lemonade Will Never Get Profitable Until It Reduces Underwriting Losses

Lemonade will never get profitable until it can reduce its underwriting losses. LMND stock has no chance of reaching analysts' target price without a huge reduction in its underwriting loss ratio.

All Hail Caesars Entertainment as New Eldorado Owner Deals Winning Hands

Eldorado has taken on a lot of debt to buy CZR stock and is now betting that a flood of profit from online gambling can retire it.

Hold Your Facebook Shares as the Company Fights for Legitimacy

In a contentious election year, Facebook has opportunities to repair its image and that's potentially good news for Facebook stock holders.

Workhorse Group Stock Needs to Recharge

Workhorse Group is a niche player in the fast-growing electric vehicle sector, focusing on electric-powered delivery vehicles. Its stock has risen more than 2,000% this year but investors should think carefully before taking a position.

Xpeng News: Why Tesla EV Rival XPEV Stock Is Revving Up 10% Today

Xpeng (XPEV) is in the news Mondy after announcing recent delivery data for its electric vehicles (EV) in September as well as Q3.

Greenpro Capital News: Why GRNQ Stock Is Skyrocketing 72% Today

Greenpro Capital (GRNQ) news for Monday includes plans to launch satellites into orbit sending GRNQ stock rocketing higher.

Regeneron Pharmaceuticals Stock Shoots Up 8% on Trump Treatment

Regeneron Pharmaceuticals (REGN) stock is soaring Monday on news that its treatment for the coronavirus was used on President Trump.

CrowdStrike Stock Gets a 4% Boost From Analyst Upgrade

CrowdStrike (CRWD) stock is on the rise Monday after Goldman Sachs analyst Brian Essex announced an upgrade for CRWD stock.

Nvidia News: 20 Reasons NVDA Stock Jumped 4% Today

Nvidia (NVDA) is making news on Monday after releasing a large collection of announcements that sent NVDA stock rising higher.

Why Dr. Fauci Holds the Key for Edge Services Provider Fastly

Not surprisingly, FSLY stock tracks closely with novel coronavirus cases due to the implications of higher data services demand. Because of that, the trajectory of Fastly depends on Dr. Fauci or more specifically, whether Americans will listen to him.

Investors Should Proceed With Caution in Sorrento Stock

After running up more than 1,000% this year, Sorrento Therapeutic's stock has pulled back with the broader market in September and is now down 43% from its peak. This retrenchment has spooked many investors. However, patient investors who are willing to stick with Sorrento, or those who buy at the current price, may be rewarded with big future returns.